EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The role of IL-8 in cancer development and its impact on immunotherapy resistance

Clara Meier, Angela Brieger

European Journal of Cancer · 2025-03 · 218 · 115267

DOI: 10.1016/j.ejca.2025.115267 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2025-03. Verfasst von Clara Meier und 1 weiteren Autor:innen. Beteiligte Einrichtung: Goethe University Frankfurt, University Hospital, Medical Clinic 1, Biomedical Research Laboratory, Frankfurt am Main, Germany. Hauptthemen laut MEDLINE: Neoplasms, Interleukin-8, Immunotherapy, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Goethe University Frankfurt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumors are structures of high complexity. Plurality of their structural and functional components - heterogeneity, diversity, directionality, interdependence and integration of signaling pathways - seem to follow isolated local rules, whereby a superordinate structure remains largely unknown. Understanding the complexity of cancer is the mainstay in finding determinants and developing effective therapies. Interleukin 8 (IL-8) is a potent pro-inflammatory chemokine that is significantly elevated in many different tumor entities. In contrast to its initially postulated anti-tumor properties, an increasing number of studies have been published in recent years linking this chemokine with tumor-promoting features and poor prognosis. This review summarizes the current state and diversity of the role of IL-8 in the development of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsInterleukin-8ImmunotherapyDrug Resistance, NeoplasmHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

AngiogenesisEMTImmunotherapy improvementInterleukin 8InvasionMetastasisMigrationTherapy optimization

Substanzen

Interleukin-8

Autor:innen und Institutionen

  • Goethe University Frankfurt, University Hospital, Medical Clinic 1, Biomedical Research Laboratory, Frankfurt am Main, Germany.
  • Goethe University Frankfurt, University Hospital, Medical Clinic 1, Biomedical Research Laboratory, Frankfurt am Main, Germany. Electronic address: a.brieger@em.uni-frankfurt.de.

Förderung

  • Goethe University Frankfurt

Zitieren

APA

Meier, C., & Brieger, A. (2025). The role of IL-8 in cancer development and its impact on immunotherapy resistance. European Journal of Cancer, 218, 115267. https://doi.org/10.1016/j.ejca.2025.115267

Vancouver

Meier C, Brieger A. The role of IL-8 in cancer development and its impact on immunotherapy resistance. European Journal of Cancer. 2025;218:115267. doi:10.1016/j.ejca.2025.115267

BibTeX
@article{Meier2025,
  author = {Meier, Clara and Brieger, Angela},
  title = {The role of IL-8 in cancer development and its impact on immunotherapy resistance},
  journal = {European Journal of Cancer},
  year = {2025},
  volume = {218},
  pages = {115267},
  doi = {10.1016/j.ejca.2025.115267}
}
Kostenlos starten →